The short answer
Proopiomelanocortin is a precursor protein cleaved into several signalling peptides including ACTH, alpha-melanocyte-stimulating hormone and beta-endorphin. Which products emerge depends on which processing enzymes a tissue expresses, so one gene yields a stress hormone in one tissue and a pigmentation signal in another.
Key facts
- Precursor
- Proopiomelanocortin (POMC)
- Products include
- ACTH, alpha-MSH, beta-endorphin
- Determined by
- Tissue-specific processing enzymes
- alpha-MSH relationship
- ACTH(1-13), acetylated and amidated
- Evolution review
- Dores 2011 (PMID 21388402)
- Relevant here
- Semax, MT-2 and KPV all derive from it
Why one gene yields several hormones
Making one long precursor and cutting it differently in different places is an efficient design. The same transcript can produce a stress hormone in one tissue and a pigmentation signal in another, with the outcome determined by which prohormone convertases that tissue expresses rather than by which gene is transcribed.
The relationship between ACTH and alpha-MSH
Alpha-MSH corresponds to the first thirteen residues of ACTH, with an acetyl group added at the N-terminus and the C-terminus amidated. It is not a separate sequence that happens to resemble ACTH. It is the same stretch of the precursor, released by a further cleavage and then chemically capped at both ends.
Research material referenced
Semax 10mg, third-party HPLC tested
Why the older literature writes MSH/ACTH
Because for the shared region the distinction does not arise. Sandman and colleagues published in the Journal of Clinical Endocrinology and Metabolism in 1977 on MSH/ACTH 4-10 and measures of attention, writing both names because residues 4 to 10 belong to both hormones. That notation is a direct record of the structural relationship.
What the capping changes
N-terminal acetylation and C-terminal amidation both remove a charged group. That alters receptor preference and also removes the free termini exopeptidases require, the same protective logic seen in MT-2, which carries both modifications deliberately. Processing is not merely cutting; it is finishing.
The evolutionary picture
Dores reviewed the origin, phylogeny and post-translational processing of POMC and the melanocortins in the Annals of the New York Academy of Sciences in 2011. The system is ancient and conserved, which is part of why the same short sequences recur across so many species and why fragments of them have been studied for decades.
Why this matters for reading this catalogue
Three separate product categories on this site (Semax, MT-2 and KPV) descend from this one precursor region. They are sold and described independently, and structurally they are neighbouring or overlapping pieces of the same short hormone. Nothing supplied here is a licensed medicine and no claim is made about any of them.
Frequently asked questions
What is POMC?
Proopiomelanocortin, a precursor protein cleaved into several signalling peptides including ACTH, alpha-MSH and beta-endorphin.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedDores RM, Evolution of POMC: origin, phylogeny, posttranslational processing, and the melanocortins. Ann N Y Acad Sci 2011 (PMID 21388402)pubmed.ncbi.nlm.nih.gov
- PubMedSandman CA et al., MSH/ACTH 4-10 influences behavioral and physiological measures of attention. J Clin Endocrinol Metab 1977 (PMID 192754)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · alpha-MSH (CID 16133793)pubchem.ncbi.nlm.nih.gov
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More Semax (ACTH Fragment Peptide) articles
- Semax, MT-2 and KPV Are Pieces of the Same SequenceSemax keeps alpha-MSH residues 4-7. MT-2's core is residues 6-9. KPV is 11-13. Three product categories carved from one 13-residue hormone.
- Where This Line of Research StartedBefore Semax existed, ACTH(4-10) itself was studied for effects on memory and attention. Two 1970s papers set the question that Semax inherited.
- What the Melanocortin Neuroprotection Literature ReportsCatania 2008 reviewed neuroprotective actions of melanocortins. Giuliani 2006 examined MC4R-stimulating melanocortins in cerebral ischaemia models.
- A Mechanism Layer Below Gene ExpressionKolbaev 2025 examined Semax and calcium dynamics in rat brain neurons - a faster timescale than the neurotrophin expression work.
- What the Animal Behavioural Work ReportsGlazova 2021 examined Semax against alterations following early-life fluvoxamine exposure in rats. Why the model design is the interesting part.